BIMT Stock Overview
Engages in the research and development and production, distribution, and sale of natural ß-carotene health food products. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Bitmis Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$2.20 |
52 Week High | US$4.06 |
52 Week Low | US$2.20 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | -20.86% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -56.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
BIMT | US Professional Services | US Market | |
---|---|---|---|
7D | 0% | -0.4% | 0.3% |
1Y | n/a | 21.2% | 31.1% |
Return vs Industry: Insufficient data to determine how BIMT performed against the US Professional Services industry.
Return vs Market: Insufficient data to determine how BIMT performed against the US Market.
Price Volatility
BIMT volatility | |
---|---|
BIMT Average Weekly Movement | n/a |
Professional Services Industry Average Movement | 5.5% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BIMT's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine BIMT's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | 11 | Sun Xiuzhi | n/a |
Bitmis Corp. engages in the research and development and production, distribution, and sale of natural ß-carotene health food products. The company was incorporated in 2016 and is based in Panjin, China.
Bitmis Corp. Fundamentals Summary
BIMT fundamental statistics | |
---|---|
Market cap | US$15.95m |
Earnings (TTM) | -US$163.79k |
Revenue (TTM) | US$1.45m |
11.0x
P/S Ratio-97.4x
P/E RatioIs BIMT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BIMT income statement (TTM) | |
---|---|
Revenue | US$1.45m |
Cost of Revenue | US$638.50k |
Gross Profit | US$808.28k |
Other Expenses | US$972.06k |
Earnings | -US$163.79k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.023 |
Gross Margin | 55.87% |
Net Profit Margin | -11.32% |
Debt/Equity Ratio | 0% |
How did BIMT perform over the long term?
See historical performance and comparison